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Abstract
The evaluation of small bowel in inflammatory bowel disease (IBD) is mainly 
performed in cases with newly diagnosed or suspected Crohn’s disease (CD). 
The available modalities for small bowel evaluation include radiological imag-
ing (barium meal follow through, magnetic resonance enteroclysis, computed 
tomography enteroclysis) and small bowel endoscopy also known as enteroscopy. 
The main advantage of small bowel endoscopy over radiological imaging is that it 
allows for obtaining biopsy specimen required for histological confirmation of the 
diagnosis. Various endoscopic modalities for endoscopic evaluation of small bowel 
include push enteroscopy and device assisted enteroscopy (DAE). Push enteroscopy 
allows only limited evaluation of proximal small bowel. Therefore, DAE is generally 
preferred over push enteroscopy for small bowel evaluation. DAE includes single 
balloon enteroscopy, double balloon enteroscopy, and spiral enteroscopy. The avail-
able literature suggests that there is no significant difference in the diagnostic yield 
among the available DAE devices. Therefore, the choice of DAE is largely dependent 
on the availability as well as local expertise. More recently, motorised spiral enteros-
copy has been introduced. The main advantage of this novel DAE is ease of use with 
the possibility of evaluating the entire small bowel via per-oral route. However, the 
data regarding the use of motorised spiral enteroscopy is limited and comparative 
trials are required in future.
Keywords: small bowel, endoscopy, advances
1. Introduction
Evaluation of the small bowel in inflammatory bowel disease (IBD) is indicated 
primarily in patients with newly diagnosed or suspected Crohn’s disease (CD) [1]. 
Small bowel evaluation can also be helpful in IBD- unclassified (IBD-U) who can be 
re-classified as CD in a significant number of cases. Small bowel evaluation in these 
settings can be done by imaging (barium meal follow through - BMFT, magnetic 
resonance enterography/enteroclysis - MRE, computed tomography enterography/
enteroclysis -CTE) or by endoscopy. Small bowel endoscopy refers to endoluminal 
examination of the small bowel. Endoscopic evaluation of small bowel can be done 
by small bowel video capsule endoscopy (VCE) (Figure 1A), push enteroscopy, 
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device assisted enteroscopy (DAE) (which includes single balloon enteroscopy- 
SBE, double balloon enteroscopy - DBE, spiral enteroscopy, novel motorised spiral 
enteroscopy - NMSE and balloon guided endoscopy) (Figure 1C) and intra-opera-
tive enteroscopy (IOE) (Figure 1D) [2].
In about two-thirds of patients with CD, small bowel is involved at diagnosis 
[3]. Among them, 90% have involvement of terminal ileum. Skip lesions in 
terminal ileum can lead to false negative results. So for diagnosis of suspected 
CD, ileo-colonoscopy is the first line investigation [4]. VCE is the preferred initial 
diagnostic modality in cases with suspected CD and negative ileo-colonoscopy in 
the absence of obstructive symptoms or known stenosis. However, small bowel 
evaluation is warranted in all newly diagnosed cases of CD as small bowel is 
involved in every 2 out of 3 CD patients and the involvement can be discontinuous. 
In this scenario, cross sectional imaging (CTE/MRE) is preferred over VCE due to 
its potential to assess transmural and extra-luminal disease. VCE is indicated sub-
sequently if cross sectional imaging is non-contributory. Patients with suspected 
small bowel involvement on cross sectional imaging or VCE, DAE with small bowel 
biopsy can provide definitive evidence of CD. Additionally, DAE is recommended 
for treatment of small bowel strictures amenable for endoscopic therapy, small 
bowel bleeding and retrieval of foreign bodies/retained capsule. For assessing the 
response to therapy in small bowel CD, VCE can be considered in primarily non-
stricturing CD [2]. Hence, small bowel endoscopy has major implications in the 
diagnosis and classification, therapeutic decision making and altering treatment 
outcomes in IBD [5].
Figure 1. 
Types of small bowel endoscopy. A. Video capsule endoscopy for small bowel (PillCam, given imaging ltd., 
Yokñeam Illit, Isareal), B. retained capsule removed at laparotomy, C. single balloon enteroscope (SIF-Q180, 
Olympus, Tokyo, Japan) with overture and balloon, D. intra-operative enteroscopy being performed at 
laparotomy.
3
Role of Small Bowel Endoscopy in Diagnosis and Management of Inflammatory Bowel Disease…
DOI: http://dx.doi.org/10.5772/intechopen.96006
2. Indications of SB endoscopy in IBD
The Indications of small bowel endoscopy in IBD are [2, 5]
1. Suspicion of isolated small bowel CD,
2. Assessment of small bowel involvement in patients with confirmed CD,
3. Assessment for post-operative recurrence of CD in small bowel after  
ileo-colonic resection [6],
4. Small bowel assessment in IBD-U,
5. As a therapeutic tool in small bowel CD (stricture dilatation, retained capsule 
or foreign body retrieval, haemostasis for small bowel bleed).
6. Evaluation of anaemia and unexplained abdominal symptoms in cases with 
ulcerative colitis (UC) [7],
7. To rule out CD prior to elective colectomy in refractory UC,
8. Investigate anaemia after ileal pouch anal anastomosis (IPAA) in UC [8].
3. Role of small bowel endoscopy in suspected CD
There is no single reference standard for diagnosis of CD. Constellation of 
clinical history, biochemical and stool biomarkers, endoscopy, cross sectional 
imaging and histopathology is required for diagnosis of CD [9, 10]. Upto 30% CD 
patients have isolated small bowel disease. Improvement in endoscopic techniques 
(VCE, DAE, NMSE) as well as radiographic techniques (CTE/MRE) have revolu-
tionised the diagnosis of small bowel CD [5]. However, options for histopathologi-
cal confirmation in isolated CD is still limited, which is important in resource 
limited countries where infections (eg. tuberculosis) still predominate and needs 
to be excluded prior to initiation of therapy [11].
4. VCE in CD
The original VCE (PillCam, Given imaging Ltd., Yokñeam Illit, Isareal) 
(Figure 1A) was designed for visualisation of small bowel which has undergone 
many modifications such as higher image resolution and increasing diagnostic 
yield by faster adjustable frame rate and real time analysis capability [12].
4.1 VCE in suspected small bowel CD
European society of gastrointestinal endoscopy (ESGE) recommends VCE as 
the first line investigation in suspected small bowel CD in whom ileo-colonoscopy 
is negative in the absence of obstructive symptoms/known stenosis (Figure 2) [2]. 
This recommendation is based on the high sensitivity and negative predictive value 
(NPV)(ranging from 96–100%) of VCE in small bowel CD. However, the accuracy 
and diagnostic yield of VCE in suspected CD could not be determined precisely due 
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to lack of gold standard for CD diagnosis and non-specific nature of findings on 
VCE. The lesions detected in VCE can be due to other causes such as non-steroidal 
anti-inflammatory drugs (NSAIDs) use, cryptogenic multifocal ulcerated stenosing 
enteritis, intestine tuberculosis, lymphoma, small bowel malignancy and intestinal 
Behcet’s disease. VCE findings like small mucosal breaks or erosions are seen in 
upto 20% of normal individuals. Hence, the positive predictive value (PPV) of 
VCE is dependent on the patient population and criteria for CD diagnosis in VCE 
[13]. Lewis score (LS) can be helpful in this regard. LS <135 signifies clinically 
non-significant lesion. LS > 135 detects significant small bowel lesion with 83.2% 
overall accuracy. LS between 135–790 is mild and > 790 indicates moderate to severe 
disease [14].
4.2 VCE in confirmed small bowel CD
In patients with confirmed CD on ileo-colonoscopy, further small bowel evalu-
ation is warranted irrespective of findings on ileo-colonoscopy (Figure 2). In this 
regard, dedicated small bowel cross sectional imaging (CTE/MRE) scores over VCE 
due to the ability to assess strictures, transmural involvement, intra-abdominal 
complications (abscess/fistula), extra-intestinal manifestations and anatomical 
distribution of the disease [2]. VCE is recommended subsequently if cross sectional 
imaging is non-contributory and if VCE findings could influence management. 
Small bowel CD only visible on VCE with normal cross sectional imaging is a new 
entity. A recent retrospective study have showed that it has a more favourable 
course compared to general CD with lower risk of complicated disease and require-
ment of step up therapy [15]. If VCE is indicated in confirmed CD, functional 
patency of the bowel should be confirmed with patency capsule given high rate of 
Figure 2. 
Algorithm for small bowel evaluation in a suspected or known case of Crohn’s disease (CD). DAE- device 
assisted enteroscopy, MRE- magnetic resonance enteroclysis, CTE- computed tomography enteroclysis,  
VCE- video capsule endoscopy.
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capsule retention in known CD (upto 13%) [2, 16]. In 27–40% cases, CTE/MRE 
finding suggestive of small bowel stricture may preclude VCE. However, not all 
strictures cause significant mechanical obstruction and patency capsule can be 
useful in this scenario [5]. The negative predictive value for ruling out a stricture is 
not different between patency capsule and non-enteroclysis small bowel radiologic 
examination according to a retrospective study [17].
Meta-analysis by Dionisio et al. have shown that VCE was superior to small 
bowel follow through (SBFT)/small bowel enteroclysis (36%) and CTE (39%) 
with higher diagnostic yield (71%). In comparison, the diagnostic yield of VCE 
was inferior to MRE (79%) [18]. However, VCE is superior to CTE/MRE in 
diagnosing proximal small bowel lesions and detects small bowel lesions in 50% 
patients with previously diagnosed ileal CD [19]. VCE can also be considered when 
symptoms suggestive of small bowel disease (anaemia, malnutrition, pain abdo-
men) do not correlate with imaging findings. In a retrospective study, VCE led to 
a change in management in 45% cases in these settings [19]. VCE can be helpful in 
suspected flares of CD, where small bowel cross sectional imaging is normal [20].
Another indication of VCE is longitudinal follow up of small bowel CD to see for 
response to therapy such as mucosal healing [2]. Endoscopic mucosal healing has 
emerged as an important therapeutic target in CD as it can predict future relapses. 
In a prospective, observational cohort study from Israeli IBD Research Nucleus 
(IIRN) it was shown that VCE predicted both short and long term flare risk in 
patients with quiescent, asymptomatic CD. Increment in Lewis score was better 
than MRE global score [21]. Similarly, in a prospective study including paediatric 
CD patients, VCE based treat to target strategy significantly increased number of 
patients achieving mucosal healing or deep remission [22].
Capsule retention in established CD can be treated with an observant, conser-
vative trial of medical therapy using steroids and/or immunomodulators failing 
which endoscopic retrieval with DAE can be be attempted. Even in case of failure 
of endoscopic retrieval of retained capsule, most of the patients can be managed 
conservatively in the absence of obstructive symptoms [23]. Only a minority 
finally require surgery (Figure 1B). In a retrospective study of more than 2300 
patients, among 301 CD patients (196 with confirmed small bowel involvement), 5 
(1.6%) developed capsule retention but only 2 required surgical intervention [24].
4.3 Role of VCE scores to evaluate CD
Objective clinical activity scores are recommended to assess disease severity, small 
bowel involvement and response to medical therapy [2]. However, it should be borne 
in mind that these scores are for assessing type, location and severity of small bowel 
involvement but not for diagnosis of small bowel CD. For diagnosis of small bowel 
CD, Mow et al. proposed a cut off of more than 3 ulcers which is widely used for 
diagnosis of CD and has modest positive predictive value (PPV): 50–70% [25]. This 
however does not give any idea about location, severity and other inflammatory fea-
tures such as edema and stenosis [2, 13]. There are two widely used validated scores 
to assess severity of small bowel CD on VCE: the Lewis score (LS) and the Capsule 
endoscopy Crohn’s disease activity index (CECDAI) (Tables 1 and 2) [26, 27]. LS is 
based upon distribution and presence of ulcers (Figure 3A, B), villous edema and 
stenosis (Figure 3C). CECDAI evaluates severity of inflammation, extent of disease 
and stenosis. Among the two, CECDAI is simpler and was shown to be more reflec-
tive for active small bowel inflammation than LS in a comparative study [28]. There is 
strong correlation between LS and CECDAI but only moderate correlation with stool 
biomarkers such as faecal calprotectin [29]. A study showed that LS between 135–790 
was equivalent to 4.9–6.9 score in CECDAI [28].
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In a retrospective study on patients with established CD, VCE led to treatment 
escalation in 45% patients. The indications of small bowel VCE were unexplained 
anaemia, discrepancy between symptoms and imaging, evaluation of full extent of 
CD to document mucosal healing [30]. Nevertheless, the risk of capsule retention 
even with normal cross sectional imaging study should be kept in mind in estab-
lished CD prior to VCE and hence patency capsules are strongly recommended [12].
4.4 Role of patency capsule
Patency capsule use is strongly recommended in stablished CD prior to small 
bowel VCE to assess functional patency of small bowel. Patency capsule can be used 
selectively (in patients with symptoms of intestinal obstruction/history of intesti-
nal obstruction or surgery/ patients with stricture on cross sectional imaging) or 
non-selectively (in all CD patients). A retrospective multi-center study have shown 
that the risk capsule retention was not significantly different with non-selective use 
(2.1%) compared to elective use (1.5%). But retention rate is as high as 11% after 
positive patency test [31].
Parameters Number Longitudinal extent Descriptors
First tertile
Villous appearance Normal - 0
Edematous - 1
Short segment - 8









Short segment - 5 
Longsegment-10





Villous appearance Normal - 0 Short segment - 8 Single - 1
Edematous - 1 Long segment - 12 Patchy −14
Whole tertile - 20 Diffuse - 17
Ulcer None-0 Short segment - 5 <1/4–9
Single - 3 Long segment - 10 1/4–1/2–12
Few-5 Whole tertile - 15 >1/2–18
Multiple - 10
Third tertile
Villous appearance Normal - 0
Edematous - 1
Short segment - 8









Short segment - 5 
Longsegment-10




Stenosis (rated for the whole 
study)
Stenosis None-0 Ulcerated - 24 Traversed - 7
Single −14 Non-ulcerated - 2 Not traversed - 10
Multiple - 20
Table 1. 
The Lewis score for the assessment of small bowel lesions using small bowel capsule Endoscopy [26].
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Two types of patency capsules have been described: the Given patency capsule 
(M2A) and the Agile patency capsule. Agile capsule has two timer plugs compared 
to one timer plug in Given patency capsule. Agile capsule starts dissolving after 
30 hours compared to 40–100 hours with Given patency capsule. Given capsule is 
composed of lactose whereas Agile capsule is composed of dissolvable components 
surrounding a small radio frequency identification tag which can be detectable by 
X ray [32, 33]. Rare cases of symptomatic intestinal occlusion have been reported 
with patency capsules [33, 34]. Agile capsule further reduces the risk of symptom-
atic intestinal obstruction. Hence, risk of symptomatic obstruction is minimal and 
patency capsules can be used safely. Most of the cases of abdominal pain due to 
obstruction is relieved by conservative measures with only a small minority requir-
ing endoscopic or surgical intervention [33, 35].
Given unclear benefit of non-selective use of patency capsules in CD and high 
risk of capsule retention in CD, the use of patency capsule should be based on 
clinical history, imaging finding, clinician’s discretion and availability.
4.5 Assessment of postoperative CD recurrence
Intestinal resection is eventually required in upto three fourth of CD patients 
after 20 years of disease [36]. Postoperative recurrence after ileo-colonic resec-
tion can occur in upto 70% patients after 20 years post surgery. Ileal lesions can be 
scored by Rutgreet’s score at the first ileocolonoscopy (ideally at 6 months postop-





1 = Mild to moderate edema/hyperemia/denudation
2 = Severe edema/hyperemia/denudation
3 = Bleeding, exudate, aphthae, erosion, small ulcer (≥ 0.5 cm)
4 = Moderate ulcer (0.5–2 cm), pseudopolyp
5 = Large ulcer (2 cm)
B. Extent of disease score
0 = None
1 = Focal disease (single segment)






Segmental score = A × B + C
Total score = (A1 × B1 + C1) + (A2 × B2 + C2)
Table 2. 
The capsule endoscopy Crohn’s disease activity index (CECDAI) for the assessment of small bowel lesions using 
small bowel capsule Endoscopy [27].
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than 5 aphthous lesions: i2- >5 aphthous lesions with normal mucosa between the 
lesions, or skip areas of larger lesions or lesions confined to the ileocolonic anas-
tomosis (i.e., <1 cm in length); i3-diffuse aphthous ileitis with diffusely inflamed 
mucosa; i,4-diffuse inflammation with larger ulcers, nodules, and/or narrowing. 
Figure 3. 
Small bowel capsule endoscopy (A-C) and enteroscopy (D-F) in Crohn’s disease (CD). A and B showing ulcers 
in CD, C. ulcerated stricture in CD, D. large deep ulcer in CD on device assisted enteroscopy (DAE), E. tight 
inflammatory stricture in CD, F. mildly inflamed stricture in CD on DAE.
Figure 4. 
Post-operative recurrence of Crohn’s disease (CD) (A-B) and endoscopic management of CD strictures. A. 
Ileal recurrence of CD on ileoscopy. B. Anastomotic site recurrence of CD after ileo-cecal resection in CD 
seen on colonoscopy. C. Inflammatory stricture in CD- not ideal for endoscopic dilatation, D and E- mild or 
non- inflammatory fibrotic stricture - ideal for endoscopic dilatation, F. endoscopic balloon dilatation being 
performed in CD stricture.
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Apart from prediction of post operative recurrence, treatment can be decided based 
upon the scoring system for recurrent CD [37].
Ileo-colonoscopy is the standard test to diagnose post operative recurrence of 
CD (Figure 4A, B), but emerging data shows that VCE can diagnose CD recur-
rence in significantly higher number of patients compared to ileo-colonoscopy 
and can lead to change in management in more than half of the patients [38–40]. 
A recent study has shown that ileal rather than anastomotic recurrence is more 
likely to predict long term outcomes in CD (Figure 4A, B) [41]. Hence, VCE has 
the potential to improve clinical outcomes in postoperative CD beyond the scope of 
ileo-colonoscopy.
4.6 Assessment of IBD-unclassified (IBD-U)
VCE in IBD-U can detect new small bowel lesions compatible with CD in 
17–70% patients. However, a normal VCE can not preclude the future evolution of 
new small bowel lesions suggestive of CD [42, 43]. In a study 5/25 (20%) IBD- U 
patients with normal VCE developed CD on follow up [44]. This is particularly 
important in paediatric IBD. Additional information provided by VCE can impact 
management in this scenario [45].
5. Enteroscopy in IBD
The drawbacks of VCE like lack of therapeutic ability, low specificity and 
inability to perform histological confirmation are circumvented by DAE. DAE 
includes double balloon enteroscopy (DBE), single balloon enteroscopy (SBE), 
balloon guided enteroscopy (BGE) and spiral enteroscopy. The detailed technical 
aspects of all DAE techniques are out of the scope of the current chapter.
5.1 SBE/DBE
SBE, in contrast to DBE does not have any balloon at the tip of the entero-
scope and hence handling of the balloon control unit is easier. DBE may be 
preferred over SBE in the presence of adhesions. Additionally, during retrograde 
DAE, which is technically more difficult than antegrade DAE, SBE may be 
more prone to backward slippage compared to DBE due to lack of balloon at the 
enteroscope tip [46].
5.2 BGE
A novel through the scope (TTS), on-demand balloon assisted enteroscopy have 
been recently described which can be performed by push and pull technique by a 
disposable advancing balloon through the working channel of a colonoscope with 
a minimal working channel diameter of 3.7 mm. The advantage of this technique 
is feasibility, safety and shorter procedure duration without adverse events. The 
learning curve is also smaller as compared to other DAE techniques. The main draw-
back of this procedure is sub-optimal stability of endoscope during therapeutic 
procedures due to lack of aching balloon. This has been recently overcome by using 
a colonoscope with an integrated latex free balloon at the bending section. In a 
multi-centre study in adults, the average insertion length were 158 cm (50–350 cm) 
and 89 cm (20–150 cm) from antegrade and retrograde approach respectively, with 
an average procedure time of 15.5 minutes [47]. More recently, the feasibility and 
safety of this NaviAid AB device (Smart Medical Systems Ltd., Ra’anana, Israel) has 
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been shown in paediatric population [48]. Therapeutic interventions can be per-
formed after removing the balloon catheter. This novel technique obviates the need 
for a enteroscope and setting up of over-tube balloons.
5.3 SE/NMSE
Spiral enteroscopy(SE) involves the use of over-tube with raised spiral edges 
which is rotated clockwise for advancement of enteroscope pleating small bowel 
loops. The over-tube has been now been replaced by novel motorised spiral enteros-
copy (NMSE) composed of a reusable endoscope with integrated motor permitting 
rotation of a short spiral over-tube in the insertion tube portion of the endoscope 
and a motor control unit. The motor control unit is composed of a foot pedal and 
visual force gauge. The advantages of NMSE are shorter procedure time, relative 
ease of use, high diagnostic yield (>80%), higher total enteroscopy rates (>60%) 
[49–51]. Therapeutic interventions like stricture dilatation and retrieval of retained 
capsule endoscope have been described with NMSE [52]. Due to large diameter of 
overture in NMSE, it is not suitable for use in children.
5.4 Indications of DAE in CD
DAE in CD is indicated particularly in suspected isolated small bowel CD in 
whom ileo-colonoscopy/ small bowel cross sectional imaging are inconclusive and 
histological diagnosis can alter patient management (Figure 3D-F). In patients with 
established CD, DAE can diagnose and treat stenotic complications (Figure 4C-F), 
assess mucosal healing for adjusting medical therapy and precisely locate lesions to 
direct targeted resection (Figure 2) [9].
DAE in suspected and established CD is done for diagnostic and therapeutic 
intent respectively. In suspected CD, DAE is performed to confirm CD beyond the 
reach of endoscopy and ileo-colonoscopy by obtaining biopsy and thus excluding 
alternative diagnosis like tuberculosis and small bowel malignancy. The diagnostic 
yield ranges between 22–70% in suspected CD.
5.4.1 Diagnostic DAE
Diagnostic yield is particularly higher if DAE is preceded by other small bowel 
investigations like CTE/MRE/VCE which help to identify the lesion and guide 
insertion route (oral or rectal). Total enteroscopy rates in this setting ranges from 
20–80% [53, 54]. Diagnostic yield of DAE is comparable to VCE according to two 
meta-analysis which concluded that VCE should be considered first due to non-
invasive nature [55, 56]. But, histological confirmation can not be obtained by VCE 
which is important in areas where infections (like tuberculosis) predominate. It 
should be borne in mind that DAE is technically challenging specially in the pres-
ence of adhesions, associated with higher rates of complications (0.72% major com-
plications rate, 10 times higher perforation rate compared to colonoscopy) in CD 
and requires deep sedation/general anaesthesia [57, 58]. Perforation risk is higher in 
patients with active CD, altered anatomy and anastomotic ulcerations [58]. Hence, 
DAE should be performed only if the findings can alter therapeutic management. 
In a prospective study, DAE led to step up in therapy in three forth of CD patients 
leading to clinical remission in nearly 90% patients [59].
Most of the studies on DAE in CD patients has been done with SBE or DBE. The 
diagnostic yield (Table 3) of DAE in suspected and known CD are 27%–79% and 
53%–87% respectively. The agreement between small bowel imaging and DAE is 
higher in patients with known CD (75.6%) compared to those with suspected CD 































































Prospective 15 (IBD) 16 (IBD)
Holleran et al, 
2018
SBE Adult CD Retrospective 13 39 39 77 69
Tun et al, 2016 DBE Adult CD Retrospective 100 0 45




Adult CD Retrospective 29 41.4 17
Rahman et al, 
2015
DBE Adult CD Retrospective 43 38 79 87 77 82
Navaneethan et 
al, 2014
SBE or DBE Adult CD Retrospective 22 43 27 53 53
Schulz et al, 
2014
DBE Adult CD Retrospective 16 0 69
Urs et al, 2014 DBE Paediatric 
CD





Prospective 8 4 75 75




Prospective 14 6 57 83
Di Nardo, 2012 SBE Paediatric 
CD
Prospective 16 14 87 64
Möschler et al, 
2011
DBE Adult CD Prospective 193 47
Kondo et al, 
2010


































Mensink et al, 
2009
DBE Adult CD Retrospective 0 40 60 75
Table 3. 
Summary of studies on diagnostic yield of device assisted enteroscopy (DAE) in Crohn’s disease (CD); SBE- single balloon enteroscopy, DBE- double balloon enteroscopy, BGE- balloon guided 
enteroscopy [69–78, 81–86]
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(36.4%). The diagnostic yield is higher if DAE is preceded by prior small bowel 
evaluation to decide the insertion route. The diagnostic yield drops drastically if 
DAE is performed for non-specific abdominal symptoms. DAE can significantly 
impact patient management in 17% to 82% [60–68].
5.4.2 Therapeutic DAE
DAE can be performed with therapeutic intent in established CD to dilate short 
(<5 cm), non-inflammatory strictures (4E-F), insert stents, inject intra-lesional 
steroid, remove foreign body like capsule or Bezoar and rarely to treat major 
haemorrhage in CD. Reported technical success for stricture dilatation ranges from 
60–80% and perforation rates as high as 9% has been described [69].
Strictures in Crohn’s disease (CD) are secondary to inflammation, fibrosis, or 
both. The risk of fibrotic stricture increases with the disease duration; such stric-
tures are seen in 30% to 35% of patients within 10 years of diagnosis of CD [36]. 
Despite biologic use, the incidence of strictures remains unchanged in CD [70]. 
Endoscopic stricturotomy and balloon dilatation are the most common endoscopic 
procedures performed for CD strictures. However, both are associated with a high 
risk of recurrence, re-intervention and surgery.
The use of self-expanding metal stents (SEMS) have been reported for CD stric-
tures with high technical success rate. However, it is associated with risk of perfora-
tion, stent migration, and fistula [71, 72]. Premature stent failure is the drawback of 
biodegradable stents, used to circumvent adverse events of SEMS. Currently avail-
able biodegradable stents are not specifically designed for CD strictures [73–75].
In a recent single-center series of CD patients, removable SEMS therapy for 
short (6 cm) fibrostenotic strictures of terminal ileum/ ileocolonic anastomoses 
was technically successful in 95.8%. The stents were removed within 7 days. On 
long-term follow-up (3–50 months), none of the patients required stricture-related 
surgery [76]. The global interventional inflammatory bowel disease (IBD) group 
recommendations has positioned fully covered SEMS for refractory strictures in 
selected patients failing balloon dilatation and endoscopic stricturotomy [77].
The technical success rate (defined as successful dilatation leading to endoscope 
passage) of endoscopic balloon dilatation (EBD) for CD strictures varies from 72% 
to 100% (Table 4). The clinical success, defined as in improvement in patient’s 
obstructive symptoms, is around 60%.
The dilatation diameter varied from 12.4 to 17 mm with maximum of 20 mm. 
The recurrence rate varied from 14% to 78.5% based on duration of follow up. In 
studies with more than 3 years of follow up, the recurrence rates were 48% and 
78.5%, respectively. Overall, most recurrences can be successfully treated with 
repeat balloon dilatation with a cumulative surgery free rate of 78% at 3 years. So, 
long term high recurrence rates and need for repeated dilatation or surgery should 
be kept in mind prior to EBD for CD strictures [69, 78–82].
5.4.3 DAE in paediatric patients
DAE is safe and effective for children aged >3 years and weight > 14 kg. DAE is 
challenging in children due to small abdominal cavity, thinner small bowel wall and 
a narrow lumen requiring considerable expertise. Five studies (2 SBE, 2 DBE and 1 
BGE) have evaluated the role of DAE in paediatric IBD. In these studies, DAE either 
led to treatment escalation or was used to perform stricture dilatation. Definitive 
IBD type was ascertained in patients with IBD-U after BGE in a feasibility and 
safety study. These studies did not report any major complications with diagnostic 














Author DAE system Study design CD 
(n)
Total number 















Hirai et al, 2018 SBE or DBE Prospective 95 90 (1) 15 (8–20) 94 70 0 24 NA
Holleran et al, 
2018
SBE Retrospective 13 14 (1) 13 (12–15) 100 80 0 8 23
Sunada et al, 
2016





SBE or DBE Retrospective 6 7 (1.16) 43 100 100 16
Hirai et al, 2014 DBE Retrospective 65 NA
[12–18]
80 80 1.5 48
Gill et al, 2014 DBE Retrospective 10 17 (1.8) 13.5 (10–16.5) 80 70 20 14
Hirai et al,2010 DBE Retrospective 25 55 (2.2) NA
[12–18]
72 72 0 11 22
Kondo et al, 
2010
DBE Retrospective 8 18 (1.5) 100 87.5 0
Despott et al, 
2009
DBE Prospective 11 18 (2) 15.4 (12–20) 73 73 9 20.5 25
Ohmiya et al, 
2009
DBE Retrospective 16 NA NA [8–20] 96 69 0 16 31
Pohl et al, 2007 Push 
enteroscopy
R 16 15 (1.5) 17 (12–20) 80 60 0 10 40
Fukumoto et al, 
2007
DBE Prospective 193 35 (1.52) NA NA 74 0 12 26
Table 4. 
Summary of studies on endoscopic balloon dilatation of Crohn’s disease small bowel strictures with device assisted enteroscopy (DAE); SBE- single balloon enteroscopy, DBE- double balloon 
enteroscopy, BGE- balloon guided enteroscopy [78–82].
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mostly with therapeutic DAE. Overall complications with a large DBE series 
(n = 257) is 5.4% (10.4% in patients <10 years). The largest SBE series (n = 189) 
does not report any major adverse events except for transient pain and distension 
(28%) and one case of self limited bleeding [48, 73, 81–87].
5.4.4 Complications of DAE
Major complications like bleeding, perforation or pancreatitis with DAE are 
found in about 0.72% (which may be higher in patients with Crohn’s disease). Rate 
of perforation with DAE is around 0.11% according to results of a large Japanese 
registry of nearly thirty thousand patients. The risk of perforation was nine fold 
higher in IBD patients on steroids [88]. The rate of perforation with endoscopic 
balloon dilatation can be as high as 9% [60]. Bleeding after DAE has been reported 
in around 2.5% which is mostly self limiting [61]. Pancreatitis can occur in upto 
0.3% patients after DAE from antegrade approach [89]. In paediatric IBD settings, 
although overall complication rates 0f upto 5.4% is reported, none reported major 
complications even with therapeutic procedures [75].
6. Intra-operative enteroscopy in CD
Earlier studies have shown that IOE has useful role in surgical decision 
making in ulcers and strictures in CD [90, 91]. In our experience (unpublished 
observation), IOE helped to identify ulcers/strictures missed on initial pre-
operative evaluation (31.8%, 7/22) (Figure 1D). In case of multiple strictures, 
IOE also helped in deciding the extent of surgical resection. In 30% (6/20) of 
the cases, strictures were severe (not allowing enteroscope passage) and rest had 
mild, passable strictures. Of the subjects with severe strictures (6/20), 3 were 
judged to have mild stricture on inspection and palpation during laparotomy. 
Hence, IOE has important role in guiding surgical management of small intesti-
nal ulcers/strictures [82, 83].
7. Conclusion
Small bowel endoscopy is essential for both diagnostic and therapeutic pur-
poses in suspected and confirmed CD. This is particularly valuable for diagnosis 
when upper endoscopy, ileo-colonoscopy and cross sectional small bowel imaging 
are non-contributory or non-diagnostic. VCE is useful if there are no obstruc-
tive symptoms or known stenosis although DAE guided biopsy is important in 
scenarios when alternative pathology requires exclusion specially in countries 
where tuberculosis is endemic. Newer devices like motorised spiral enteroscopy 
and balloon guided enteroscopy have revolutionised the management of small 
bowel CD. DAE is be safe and effective in both adults and children with CD. Apart 
from therapeutic interventions like foreign body retrieval, endoscopic balloon 
dilatation, stent placement and haemostasis; small bowel endoscopy could be 
useful in postoperative CD recurrence detection and document mucosal healing 
and response to therapy.
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